Approval · Notice of Compliance 11348 · 2010
ACTEMRA: Notice of Compliance 11348
Issued April 30, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11348
- Date
- April 30, 2010
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Interleukin receptor inhibitor
Products in this notice
Medicinal ingredients
- TOCILIZUMAB 80 MG per 4ML
- TOCILIZUMAB 200 MG per 10ML
- TOCILIZUMAB 400 MG per 20ML